Portrazza 800 MG in 50 ML Injection

Dosage & administration

Recommended dose of PORTRAZZA is 800 mg (absolute dose) as an intravenous infusion over 60 minutes on Days 1 and 8 of each 3-week cycle.

biomarker testing

Portrazza clinical details

Genetic testing requirements were obtained from the NCCN guidelines for each cancer type.

drug label

Portrazza prescribing information

financial assistance

Portrazza financial assistance options

Foundation programs

under insured
no insurance
goverment insurance

Lilly Cares Foundation
Learn More

patient education

Portrazza patient education

Getting started on Portrazza

To share resource; ask patient to:
1.Pull out phone
2.Open camera
3.Scan QR code with camera
4.Tap link

Patient toolkit

Learn More

Other resources

Learn More

people also ask

Portrazza FAQs

How is the dosage of Portrazza?Portrazza is available in 1 dosages, including 16 mg/ml Injection 50 ml
What does Portrazza treat?Portrazza treats Non-Small-Cell Lung Carcinoma
What is Portrazza made of?Portrazza contains necitumumab which is a Epidermal Growth Factor Receptor Antagonist
How Is Portrazza Administered?Portrazza is administered as a Injectable
What Are The Portrazza Mechanism Of Action?Portrazza mechanism of action is HER1 Antagonists
FAQ Data Source